RDC 665/2022 FAQ - Updated October 2025
Brazil Good Manufacturing Practices for Medical Devices. Expert guidance by Pure Global regulatory specialists
Official Document
Pure Global offers comprehensive GMP consulting and certification support for medical device manufacturers, combining ISO 13485 expertise with ANVISA-specific requirements to achieve B-GMP certification under RDC 665/2022.
ISO 13485 QMS setup and Brazil-specific GMP compliance
Preparation for Medical Device Single Audit Program certification
Mock audits and documentation preparation for ANVISA inspections
Applies to all medical devices and IVDs
Replaced RDC 16/2013
Mandatory ANVISA inspection
Harmonized with international standards
Frequently Asked Questions
General Requirements
Quality Management System
Design & Development
Production & Process Controls
Inspection & Nonconforming Product
Post-Market Activities
Note: This FAQ guide provides general information about regulatory requirements and should not be considered as legal advice. Regulations are subject to change. Always consult with qualified regulatory professionals for specific guidance.
Last updated: October 2025 | Based on RDC 665/2022 official documentation

